| ASVRX | FCVAX | ASVRX / FCVAX | |
| Total Expense Ratio | 1.58 | 1.20 | 132% |
| Annual Report Gross Expense Ratio | 1.58 | 1.20 | 132% |
| Fund Existence | 17 years | 22 years | - |
| Gain YTD | 21.329 | 24.948 | 85% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.86B | 5.47B | 52% |
| Annual Yield % from dividends | 0.42 | 0.67 | 63% |
| Returns for 1 year | 1.86 | 14.70 | 13% |
| Returns for 3 years | 13.62 | 32.11 | 42% |
| Returns for 5 years | -3.42 | 19.16 | -18% |
| Returns for 10 years | 27.76 | 38.07 | 73% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ZSL | 23.35 | 0.55 | +2.41% |
| ProShares UltraShort Silver | |||
| EEMA | 119.48 | 2.14 | +1.82% |
| iShares MSCI Emerging Markets Asia ETF | |||
| IPOS | 23.22 | 0.10 | +0.44% |
| Renaissance International IPO ETF | |||
| IUSG | 191.91 | -0.24 | -0.12% |
| iShares Core S&P US Growth ETF | |||
| MAYT | 39.99 | -0.08 | -0.21% |
| AllianzIM US Equity Buffer10 May ETF | |||